NAD+ doses: injections and infusions
NAD+ is given in two ways: as a small injection under the skin or into a muscle, drawn up with an insulin syringe, or as an infusion into a vein, with the dose diluted in a bag of saline. The doses below are the ones a named source gives, with who gave them and how.
| Source | Dose and route | Schedule |
|---|---|---|
| Empower Pharmacy, a compounding pharmacypage updated | Under the skin: about 20 mg to start, raised over the next injections to about 100 mg per injection | 1 to 3 times a week; to keep up, 50 to 100 mg a week |
| NCT06919328, a registered trialplan, no results posted | 100 mg in 2 mL of bacteriostatic water, under the skin, into a muscle or into a vein | One injection, with pain and discomfort scored a minute after it |
| Grant et al., 20198 healthy men aged 30 to 55 | 750 mg in saline, into a vein over 6 hours | Once; the authors call it a common regimen in clinics |
| Reyna et al., 2026clients of a wellness clinic | 500 mg mixed with bacteriostatic water and diluted in 500 mL of saline, into a vein | Once a day for 4 days in a row: the “loading dose” of the compounding pharmacy that supplied it |
| Yu et al., 2026180 adults with heart failure, 90 on NAD+ | 10 mg in 100 mL of 5% glucose or saline, into a vein over about 40 to 60 minutes | Once a day for 7 days, in hospital, with their usual treatment |
No published human study has given NAD+ under the skin: the pharmacy’s protocol and the trial plan are the only doses under the skin found in a named source. The studies gave it into a vein. The pharmacy in the Reyna study is Empower Pharmacy, the one whose protocol heads the table.
Each injection dose in units
An infusion dose is drawn up with a larger syringe: 500 mg at 100 mg per mL is 5 mL, more than a 1 mL insulin syringe holds. An injection dose is a fraction of a mL, and the units depend on the strength of the vial.
| Dose | at 50 mg/mL | at 100 mg/mL | at 200 mg/mL |
|---|---|---|---|
| 20 mg | 40 | 20 | 10 |
| 50 mg | 100 | 50 | 25 |
| 100 mg | over 100 | 100 | 50 |
The pharmacy sells NAD+ ready mixed at 100 mg per mL and 200 mg per mL. For a ready-mixed vial, enter the mg and the mL in it; for a powder vial, the mg and the water you added.
The example in the calculator. A 500 mg vial with 5 mL is 100 mg per mL. The 20 mg starting dose is 20 ÷ 100 = 0.2 mL, which is 20 units on a U-100 syringe, and the vial holds 25 such doses. At 200 mg per mL the same dose is 0.1 mL, 10 units.
Is NAD+ FDA-approved?
No. The FDA has approved no drug made of NAD+. Pharmacies compound it under section 503A, where the FDA is still evaluating it.
- FDA
- No approved drug: no product with NAD+ (nadide) as its ingredient is in the Drugs@FDA data files of 2026-10-27, and DailyMed holds no FDA-approved label for one.
- Compounding
- “Nicotinamide Adenine Dinucleotide (NAD)” and its reduced form NADH are in Category 1 of the bulk substances nominated for compounding under section 503A: substances under evaluation, for which the FDA does not intend to act against a pharmacy that compounds them under the conditions of its guidance. NAD was in Category 1 on the list of 2024-09-27 as well.
- Advisory committee
- Not on the agenda of the Pharmacy Compounding Advisory Committee (meetings of October and December 2024 and July 2026).
- WADA
- Not named on the 2026 Prohibited List or on the 2027 List. Its method M2.2 prohibits at all times infusions and injections of “more than a total of 100 mL per 12-hour period”, except those legitimately received in hospital treatment, surgery or clinical diagnostic investigations; the limit counts the volume, whatever it holds.
- Trials
- No trial of NAD+ by injection or infusion has posted results on ClinicalTrials.gov.
Other calculators
- Peptide reconstitution calculatorThe water to add to the vial so your dose is the number of units you want to draw.
- Insulin syringe units to mLUnits on a U-100 insulin syringe in mL, and mL in units.
- HGH reconstitution calculatorUnits to draw for an HGH dose in IU or mg, from the vial and the water you added.
- Peptide calculatorUnits to draw for your dose, from the peptide in the vial and the water you added.
Questions
How many units is 100 mg of NAD+?
It depends on the strength of the vial. At 200 mg per mL it is 50 units, at 100 mg per mL 100 units, a full 1 mL syringe. At 50 mg per mL, 100 mg in 2 mL as in trial NCT06919328, it is 2 mL, more than a 1 mL syringe holds.
How much water goes into a 500 mg NAD+ vial?
The water only sets the strength: 500 mg with 5 mL is 100 mg per mL, with 2.5 mL 200 mg per mL. A 20 mg dose is then 20 or 10 units. The reconstitution calculator finds the water for the units you want per dose. A ready-mixed vial takes no water: enter its mg and mL.
Is NAD+ a peptide?
No. NAD+, nicotinamide adenine dinucleotide, is a coenzyme made of two nucleotides joined through their phosphate groups, not a chain of amino acids. The vial math is the same: the mg in the vial, the mL of liquid and the mg in each dose.
Is NAD+ FDA-approved?
No. No approved drug is made of it; pharmacies compound it under section 503A, where the FDA lists it in Category 1, under evaluation (list of 2026-05-14).
Does WADA ban NAD+?
The Prohibited List does not name it. Its rule M2.2 limits infusions and injections to a total of 100 mL in 12 hours outside hospital treatment, surgery and diagnostic investigations, whatever they contain; an infusion in a 500 mL bag is over that volume.
Sources
- Grant R et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+Front Aging Neurosci 2019;11:257, PubMed 31572171. 750 mg into a vein over 6 hours in 8 healthy men; a common regimen in clinics.
- Reyna K et al. Intravenous infusion of NAD+ versus nicotinamide riboside: a retrospective tolerability pilot study in a real-world settingFront Aging 2026, PubMed 41704678. 500 mg in 500 mL of saline, 4 days in a row; the pharmacy’s “loading dose”.
- Yu X et al. Effect of nicotinamide adenine dinucleotide on heart failure caused by ischemic cardiomyopathy: a randomized, placebo-controlled trialAm J Cardiovasc Drugs 2026, PubMed 40954388. 10 mg in 100 mL into a vein once a day for 7 days.
- NCT06919328: absorption and tolerability of injectable Niagen+ compared to NAD+ClinicalTrials.gov, record retrieved 2026-10-29. 100 mg of NAD+ in 2 mL under the skin, into a muscle or into a vein; no results posted.
- Bulk drug substances nominated for use in compounding under section 503AFDA, list updated 2026-05-14. NAD and NADH in Category 1.
- WADA Prohibited List 2026In effect 2026-01-01. M2.2, the 100 mL per 12 hours limit on infusions and injections.